Brain-targeted delivery of Tempol-loaded nanoparticles for neurological disorders (Q39738982)

14 September 2017

Brain-targeted delivery of Tempol-loaded nanoparticles for neurological disorders (English)

1 reference

14 September 2017

0 references

Richard T Carroll

1

1 reference

14 September 2017

Deepak Bhatia

2

1 reference

14 September 2017

Werner Geldenhuys

3

1 reference

14 September 2017

Ruchi Bhatia

4

1 reference

14 September 2017

Nicholas Miladore

5

1 reference

14 September 2017

Anupam Bishayee

6

1 reference

14 September 2017

Vijaykumar Sutariya

7

1 reference

14 September 2017

1 November 2010

1 reference

Journal of Drug Targeting

14 September 2017

1 reference

14 September 2017

18

1 reference

14 September 2017

9

1 reference

14 September 2017

665-674

1 reference

Brain Peroxidase and Catalase in Parkinson Disease

14 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F10611861003639796

Effect of pluronic P85 on ATPase activity of drug efflux transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003639796

Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003639796

Mitochondrial approaches for neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003639796

Peroxynitrite in the pathogenesis of Parkinson's disease and the neuroprotective role of metallothioneins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003639796

Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003639796

Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003639796

Factors governing the in vivo tissue uptake of transferrin-coupled polyethylene glycol liposomes in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003639796

Brain drug delivery of small molecules using immunoliposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003639796

Nanoparticulate systems for brain delivery of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003639796

Neuroprotective effects of TEMPOL in central and peripheral nervous system models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003639796

Covalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003639796

Oxidative stress: the old enemy in Alzheimer's disease pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003639796

PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and drug loading ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003639796

Synthesis of pegylated immunonanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003639796

Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patients: dose-response study and correlations with plasma levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003639796

Intravenous, non-viral RNAi gene therapy of brain cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003639796

Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003639796

Enhanced growth inhibition effect of resveratrol incorporated into biodegradable nanoparticles against glioma cells is mediated by the induction of intracellular reactive oxygen species levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003639796

Vector-mediated drug delivery to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003639796

Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003639796

Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611861003639796

10.3109/10611861003639796

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference